| 000 | 01138 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250511214741.0 | ||
| 264 | 0 | _c19910219 | |
| 008 | 199102s 0 0 eng d | ||
| 022 | _a0706-7437 | ||
| 024 | 7 |
_a10.1177/070674379003500702 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShriqui, C L | |
| 245 | 0 | 0 |
_aTardive dyskinesia: legal and preventive aspects. _h[electronic resource] |
| 260 |
_bCanadian journal of psychiatry. Revue canadienne de psychiatrie _cOct 1990 |
||
| 300 |
_a576-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xetiology |
| 650 | 0 | 4 |
_aExpert Testimony _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalpractice _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aBradwejn, J | |
| 700 | 1 | _aJones, B D | |
| 773 | 0 |
_tCanadian journal of psychiatry. Revue canadienne de psychiatrie _gvol. 35 _gno. 7 _gp. 576-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/070674379003500702 _zAvailable from publisher's website |
| 999 |
_c1986276 _d1986276 |
||